Holen Sie sich die Stockscreener-App
504.82
0.98%
-5.00
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$509.82
Offen:
$514.45
24-Stunden-Volumen:
3.19M
Relative Volume:
1.53
Marktkapitalisierung:
$189.66B
Einnahmen:
$44.56B
Nettoeinkommen (Verlust:
$6.73B
KGV:
28.46
EPS:
17.7391
Netto-Cashflow:
$6.29B
1W Leistung:
-7.00%
1M Leistung:
-16.84%
6M Leistung:
+4.13%
1J Leistung:
-5.22%
1-Tages-Spanne:
$504.25
$520.35
1-Wochen-Bereich:
$493.64
$550.95
52-Wochen-Spanne:
$385.46
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
504.82 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
212.58 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
629.35 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
125.81 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
323.37 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-12-01 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Thermo Fisher Scientific (TMO) Announces $3.8 Billion Senior Not - GuruFocus
Decoding Our DNA: The Human Impact Behind SNP Genotyping’s USD 19.48 Billion Growth by 2034 - GlobeNewswire Inc.
New South Capital Management Inc. Sells 2,413 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Is Waters a Better Buy Than Thermo Fisher Scientific? - Trefis
Thermo Fisher Scientific Inc. (TMO): Our Calculation of Intrinsic Value - The Acquirer's Multiple
Thermo Fisher Issues $3.8 Billion Notes for Acquisition - TipRanks
Thermo Fisher stock slides 4%: Datavant data pact and $3.8B notes put TMO in focus - Bez Kabli
Varma Mutual Pension Insurance Co Increases Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Wealthfront Advisers LLC Acquires 6,954 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
ING Groep NV Has $15.53 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Cornerstone Investment Partners LLC Makes New Investment in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Caprock Group LLC Purchases Shares of 8,500 Thermo Fisher Scientific Inc. $TMO - MarketBeat
Atria Investments Inc Decreases Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Monash University and Thermo Fisher launch Catalyst PhD programme - BioSpectrum Asia
Insider Sell: Gianluca Pettiti Sells Shares of Thermo Fisher Sci - GuruFocus
Thermo Fisher Scientific (NYSE:TMO) EVP Gianluca Pettiti Sells 400 Shares - MarketBeat
Thermo Fisher Scientific Expands Real-World Data Interoperability and Linkage Through Strategic Collaboration with Datavant - marketscreener.com
Thermo Fisher Scientific Expands Real-World Data Interoperability and Linkage Through Strategic Coll - PharmiWeb.com
Thermo Fisher, Datavant to Partner on Linking Real-World Data to Clinical Research - Contract Pharma
Thermo Fisher Scientific Stock Outlook: Is Wall Street Bullish or Bearish? - Barchart.com
Thermo Fisher Collaborates With Datavant to Link Real-World Data With Clinical Research - 富途牛牛
Insiders At Thermo Fisher Scientific Sold US$3.6m In Stock, Alluding To Potential Weakness - Yahoo Finance
William Blair Reaffirms Their Buy Rating on Thermo Fisher (TMO) - The Globe and Mail
Thermo Fisher Scientific Expands Real-World Data Interoperability - The National Law Review
Gram Staining Systems Market Is Going to Boom |• Thermo Fisher Scientific • Merck KGaA - openPR.com
Prospera Financial Services Inc Reduces Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Impax Asset Management Group plc Sells 20,515 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
ABC Arbitrage SA Makes New $1.31 Million Investment in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific stock slides as $3.8 billion bond deal lands — what to watch next - Bez Kabli
Thermo Fisher Scientific Inc. $TMO Shares Bought by Rockland Trust Co. - MarketBeat
United States Life Science Instruments and Consumables Market - openPR.com
Edgemoor Investment Advisors Inc. Sells 5,621 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Prices $3.8 Billion Senior Notes - marketscreener.com
Midwest Trust Co Has $43.26 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Compagnie Lombard Odier SCmA Has $142.48 Million Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher (TMO) Prices $3.8 Billion Debt Offering - GuruFocus
Thermo Fisher prices $3.8B note offering - MSN
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes - marketscreener.com
Thermo Fisher prices $3.8 billion notes offering for Clario acquisition - Investing.com
Thermo Fisher Scientific Prices $3.8 Billion Note Offering - Intellectia AI
Thermo Fisher Scientific says prices $3.8 bln offering of USD-denominated senior notes - marketscreener.com
Thermo Fisher Scientific Says Prices $3.8 Bln Offering Of USD-Denominated Senior Notes - TradingView
Thermo Fisher Scientific Files Pricing Term Sheet For $3.8 Billion Four Part Senior Notes Offering - TradingView
Thermo Fisher Scientific Inc files for four-part senior notes offering size not disclosed - marketscreener.com
Exosomes Market to See Thriving Worldwide | Thermo Fisher Scientific, Inc., Bio-Techne - openPR.com
Gables Capital Management Inc. Grows Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Oppenheimer Asset Management Inc. Trims Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Nuance Investments LLC - MarketBeat
Thermo Fisher stock holds near $543 after Thursday slide as traders size up layoffs notice, data week ahead - TechStock²
Taking A Fresh Look At Thermo Fisher Scientific (TMO) Valuation After Recent Share Price Weakness - simplywall.st
Appleton Partners Inc. MA Decreases Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
1.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):